Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of sea cucumber glycosaminoglycan for acute ischemic stroke
CTR20253862Phase 3Active
- Sponsor
- Harbin Taxus Bio-Pharmaceutical
- Start
- Jan 2026
- Countries
- 1
01
Overview
A Phase 3 trial of sea cucumber glycosaminoglycan in ischemic stroke, sponsored by Harbin Taxus Bio-Pharmaceutical. Started Jan 2026; status: active.
02
Drugs
sea cucumber glycosaminoglycan
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20253862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253862.